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Abstract 
Asthma is a chronic airway inflammation which involves the interplay of different types of inflammatory cells 
and cytokines in the airway. The present study evaluates the antioxidant enzymes including superoxide 
dismutase, glutathione peroxidase and Catalase levels. The results showed a significant increase (P˂0.05) in 
erythrocyte superoxide dismutase (SOD) activity in asthmatic patients as compared to control group. While there 
were a significant decrease in glutathione peroxidase (GPx) (P˂0.05) and Catalase (CAT) (P˂0.05) activities in 
patients as compared to control group, in accordance with age, severity, smoking and family history. But, there 
were no significant changes in the enzymes levels between males and females. The results indicated that 
antioxidant enzymes could play an important role in gen- environment interaction in complex lung disease such 
as asthma.    
Keywords: MDA: Malondialdehyde, SOD: Superoxide dismutase, GPx: Glutathione peroxidase, CAT: Catalase, 
ROS: Reactive oxygen species. 
 
Introduction 
Asthma is a chronic inflammatory disease of the respiratory tract of the unknown etiology. Asthma is a complex 
disorder involving biochemical, autonomic, immunologic, infectious, endocrine and psychological factors in 
varying degrees in different individuals [1]. According to the world health organization (WHO), asthma is now a 
serious public health problem with over 100 million sufferers worldwide, death from this condition has reached 
over 180,000 annually [2, 3]. Asthma remains the most common chronic illness of childhood; it is regarded as 
the fifth cause of death in children [4]. These systems consist of antioxidant enzymes such as superoxide 
dismutase (SODs), glutathione peroxidase (GPx), catalase (CAT) and glutathione reductase (GRx), as well as 
non enzymatic antioxidants, such as vitamin C, E, glutathione and uric acid. 
Superoxide dismutase (SOD) is metallo enzyme that catalyzes the disputation of the superoxide anion 
to molecular oxygen and hydrogen peroxide and thus form a crucial part of the cellular antioxidant defense 
mechanism [5]. Two superoxide dismutase are enzymes have so for been described in vertebrates i. e. Cu/ Zn- 
SOD (Copper/ Zinc superoxide dismutase) and Mn- SOD (Manganese superoxide dismutase).The Cu/ Zn- SOD 
has been demonstrated in the cytoplasm and also in the inter membrane  space in mitochondria. But, Mn-SOD is 
found in the matrix space in mitochondria [6]. The enzyme SOD is considered the first line of defense because it 
firstly catalyses in the system harvesting oxygen- free radicals, therefore SOD prevents the oxidation of 
biological molecules. Local deficiency of SOD can lead to the formation of peroxy nitrite and other oxidizing 
species, while adequate SOD can scavenge superoxide anion and permit nitric oxide radical to remain active as a 
signaling molecule [7]. 
Glutathione peroxidase (GPx) are tetra metric enzymes consisting of four 22 KDa monomers, each of 
which contains a selenocysteine moiety in the active site. There are four subspecies of GPx that catalyze the 
reduction of hydrogen peroxide and organic hydro peroxides ROOH to water. This occurs with the oxidation of 
glutathione in specific tissue locations [8]. GPx1 is ubiquitous and found in the cytosol of most cells, including 
red blood cells (RBC). GPx2 is also cytosolic but is confined to the gastrointestinal tract. GPx3 occurs in the 
plasma as a glycoprotein and GPx4 interacts with complex lipids, such as cholesterol and lipoproteins damaged 
by free radicals, and is found in mitochondria [8]. 
Catalase (CAT) is an enzyme which is present mainly in the Peroxisomes of mammalian cells. It is a 
tetra metric enzyme consisting of four identical tetrahedrally arranged sub units of 60 KDa, each containing in 
its active center a heme group and NADPH [9]. Catalase acts catalytically remove hydrogen peroxides (H2O2) by 
forming water and oxygen. The present study was undertaken to evaluate the antioxidant enzymes: Superoxide 
dismutase (SOD), Glutathione peroxidase (GPx) in the erythrocyte and Catalase (CAT) concentration in the 
blood of asthmatic patients with several parameters (age, sex, severity, smoking and family history). 
 
Materials and Methods 
One hundred patients (55 males, 45 females) with asthma clinically diagnosed admitted to Allergic center from 
the first of October 2009 to the end of March 2010 in Basrah city/ Iraq whose age ranged between (7-67) years 
for males and females, divided into three groups (7-35) years, (36-50) years, (>50) years. The following 
information was recorded for asthmatic patients: age, sex, and smoking, date of admission, family history of 
allergy, sign and symptom and severity of the acute attack.  
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Those patients were classified according to the severity into three groups:  
1- Mild             2- Moderate          3- Sever 
This classification of severity depends on expert panel report; guidelines for the diagnosis and 
management of asthma, sign and symptoms were used mainly for the classification of severity [10]. Sixty 
healthy subjects (35 males, 25 females) were investigated as a control group from Public Health Center in Basra 
city aged between (18-65) years. Five mL of fresh venous blood were collected from each patient and control 
subjects. These samples were divided in to the following: 2.5 mL were added to heparin anticoagulant tubes. 
Blood samples were centrifuge at 3000 rpm for 10 minutes in order to separate the plasma. The remaining 
erythrocytes were washed three times with 0.9% NaCl, and lysate in 1:1 (V/V) of double – deionised water, 
which was lysates used for laboratories U.K..Based on [11]. Activity of glutathione peroxidase in whole blood 
was measured using a Kit (RANSEL) from Randox laboratories based on the method of [12]. Catalase was 
assayed calorimetrically at 620 nm and expressed as µmoles of H2O2 consumed min\mL of serum described by 
[13]. The reaction contain 1.0 mL of 0.01M phosphate buffer with 0.1mL of serum and 0.4mL of H2O2, the 
reaction was stopped by the addition of 2 mL of dichromate acetic acid reagent. 
 
Instruments: 
1- Spectrophotometer SP 8-100 VV pye Unicom, UK. 
2- Centrifuge, Kokusan, Japan. 
3- Vortex stirrer, Gallen Kamp, Germany. 
4- Water bath, Gallen Kamp, Germany. 
5- Stopped watch, Fisher scientific company, USA. 
 
Materials: 
The entire chemicals in this study were imported from BDH Co. and Sigma Co. 
 
Calculations: 
The concentration of Superoxide dismutase (U/mL): 
 
 
 
A1:The absorbance of the sample/30 sec. 
A2 : The absorbance of the sample/3 min. 
 
The concentration of Glutathione peroxidase GPx (U/L): 
U/L of Haemolysate = 8412 × DA340nm / minute 
GPx unit / L of whole blood = GPx U/L of Haemolysate × 41(dilution factor), 
Where: 8412 = Total volume (ml) × 1000 / Sample volume (ml) × milimolar extinction coefficient (6.3) × light 
path (1 cm). 
 
The concentration of Catalase CAT (U):          
K: Constant of rate. 
Δt: (T2-T1) equal to 15 sec. 
A1: The  absorbance/15 sec.  
A2: The absorbance/30 sec. 
Vt: The volume measured (3 ml).  
Vs: The volume of sample in mixed (2 ml). 
 
Statistical Analysis:   
Results were expressed as mean and standard deviation (SD). Statistical analysis was carried out using the SPSS. 
Program (version 15 software, SPSS Inc. Chicago, Illinois, USA). For the comparison of groups, independent 
student t test, ANOVA, Kruskal Wallis and Mann Whitney U test were used. Pearsorr S correlation between 
variable. P values of less than 0.05 were regarded as significant. 
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Results and Discussion: 
Asthma is a chronic inflammatory airway disorder associated with recruitment of inflammatory cells. It is 
characterized by reversible and variable recurrent episodes of airway obstruction that resolve spontaneously or as 
a result of treatment. Prominent symptoms include wheezing, breathlessness, chest tightness and cough, 
particularly at night and or early in the morning [14]. The results of the present study show that the activity of 
antioxidants enzymes superoxide dismutase (SOD), glutathione peroxidase (GPx) and catalase (CAT) in 
asthmatic patients. 
SOD is an enzyme that reduces the cytoplasm and mitochondrial damage induced by superoxide 
radicals. The increased activity of SOD observed in the present study (table 1 and graph 1) (P˂0.05) as compared 
to control subjects, may be indicative of increased superoxide anion (O2̇ ) ̄ generation. The over expression of 
SOD might be an adaptive response and results in increased disputation of superoxide to H2O2. It could be easily 
observed that lower limit of SOD activity in asthmatic was recorded with in the upper limit level of controls 
which ascertained the significant elevation of SOD in patients. The elevation recorded in the present study is in 
good agreement with previous studies that recorded higher RBC and SOD activity in asthmatic patients 
compared to control [15; 16; 17; 18; 19]. Increased concentration of SOD might be a compensatory response to 
the increased oxidative stress because of the increase of mitochondrial oxidation rate characterized by an over 
production of superoxide anion [19; 20; 21]. 
GPx plays a significant role in the peroxyl scavenging mechanism and in maintaining functional 
integration of the cell membrane. The significant decrease in GPx activity (P˂0.05) recorded in the present study 
(table 2 and graph 2) as compared to control could be easily correlated to the high significant elevation of lipid 
peroxides. Lower GPx level in asthmatic patients could be related to the clinical presentation of the disease and 
could explain the presence of H2O2 in the breath condensate of exhaled air which is elevated in asthmatic 
reported in previous studies [22; 23]. Decreased GPx activity has been well documented [15; 16]. This supports 
the lower GPx activities observed in the present study. High SOD activity together with low GPx activity in 
asthmatic confirms the contribution of oxidative stress in the etiology of asthma. 
CAT is responsible for detoxification of H2O2, that formed by SOD and other processes is scavenged by 
catalase that catalyzes the disputation of  H2O2 into water and molecular oxygen [24] significantly decrease for 
catalase activity (P˂0.05) in asthmatic patients compared with control as show in (table 3 and graph 3), when 
hydrogen peroxide could not be detoxified as a results catalase activity was decreased due to hydrogen peroxide 
possibly convert to hydroxyl radical by iron in asthmatic patients [25]. These significant changes in the activity 
of enzymes SOD, GPx and CAT increases with age and severity from mild to moderate than sever (P˂0.05). 
Also there were no significant differences between male and female patients as indicated in (Tables 1, 2, 3).  
These imply that patients during a cute asthmatic attack are exposed to considerable degree of lipid 
Peroxidation; it has a strong correlation with atopic asthma suggesting that oxidative stress [20]. Asthma severity 
is related to the extent of lipid Peroxidation, severity (P˂0.05) [26]. As indicated in (Tables 1, 2, 3). On the other 
hand, there were a significant difference in enzymes activates (SOD, GPx and CAT) between asthmatic smokers 
and non smokers (P˂0.05) as indicated in (Tables 1, 2, 3). 
Cigarette smoke contains high amount of free radicals such as superoxide anion (O2 ̇ ) ̄  and nitric oxide 
(NȮ) [9], gas phase can react chemically to from highly reactive free radical peroxy nitrite. In addition 
superoxide anion can react with hydrogen peroxide to form the more active hydroxyl free radical [27]. Many 
researchers have reported increased level of superoxide anion from circulating neutrophils and increased lipid 
Peroxidation products malondialdehyde (MDA) in the plasma of smokers, supporting the concept of systematic 
oxidative stress in these individuals [28].  
Also family history seems to influence the enzymes (SOD, GPx and CAT) activities as compared to 
positive and negative family history of asthmatic patients, there were a significant changes (P˂0.05) in the 
activities as shown in (Tables 1, 2, 3). Some genetic variant may only cause asthma when they are combined 
with specific environmental exposures, the genetic trait, CD14 single nucleotide polymorphism, and exposure to 
end toxin (a bacterial product). Researchers have found that the risk of asthma changes based on a person's 
genotype at CD14 and the level of end toxin exposure [28; 29]. Asthma itself may cause physiological changes in 
blood antioxidants burden associated with disease [30; 31]. 
 
Conclusion 
The present study suggests a very high production of ROS and oxidative stress in patients with asthma and 
failure of antioxidants mechanisms. 
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Table (1): Serum level of superoxide dismutase (SOD) (U/ mL) in asthmatic patients classified according to 
(Age, Sex, Severity, Smoking, Family history) and healthy control. 
P-value 
Control 
(60) 
Asthmatic patients 
(100) Variable 
Mean± SD No. Mean± SD No. 
P˂0.05 
191.162±7.879 25 224.511±9.502* 43 7-35 
Age/ year 191.600±8.603 20 223.541±9.916 37 36-50 
194.123±11.427 15 225.661±14.550 25 ˃50 
P˂0.05 
197.327±17.779 35 226.646±14.505 47 Male 
Sex 
195.217±8.935 25 221.193±12.853 53 Female 
P˂0.05 191.028±9.340 60 
209.876±10.427* 32 Mild 
Severity 215.047±7.395 17 Moderate 
221.906±9.302 51 Sever 
P˂0.05 
192.541±11.916 33 246.700±19.519* 25 Positive 
Smoking 
201.077±13.833 27 229.518±20.731 75 Negative 
P˂0.05 195.378±9.961 60 
226.590±18.565* 35 Positive 
Family history 
221.383±16.850 65 Negative 
  * The mean difference is significant at the 0.05 level 
 
 
Figure 1. Serum Superoxide dismutase (U/ml) in asthmatic patients and healthy control classified according to 
(Age, Sex, Severity, Smoking and Family history). 
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Table (2): Serum level of glutathione peroxidase (GPx) (U/ L) in asthmatic patients classified according to  (Age, 
Sex, Severity, Smoking, Family history) and healthy control. 
P-value 
Control 
(60) 
Asthmatic patients 
(100) Variable 
Mean± SD No. Mean± SD No. 
P˂0.05 
3502.331±1386.953 25 2925.250±787.564* 43 7-35 
Age/ year 3312.772±1337.986 20 2148.736±981.368 37 36-50 
3760.584±338.175 15 2429.260±1001.086 25 ˃50 
P˂0.05 
3804.781±1644.137 35 2928.916±1884.176 47 Male 
Sex 
3858.790±1974.560 25 2812.356±1655.398 53 Female 
P˂0.05 3826.341±970.328 60 
2709.005±731.5726* 32 Mild 
Severity 2426.314±632.1069 17 Moderate 
2082.321±896.7633 51 Sever 
P˂0.05 
3767.556±1128.169 33 2148.648±787.312* 25 Positive 
Smoking 
3915.384±1727.384 27 2547.305±872.849 75 Negative 
P˂0.05 3870.634±1428.651 60 
2210.978±1395.724* 35 Positive 
Family history 
2463.932±1735.913 65 Negative 
* The mean difference is significant at the 0.05 level 
 
Figure 2. Serum Glutathione peroxidase (U/L) in asthmatic patients and healthy control classified according to 
(Age, Sex, Severity, Smoking and Family history). 
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Table 3. Serum level of catalase (CAT) (U) in asthmatic patients classified according to (Age, Sex, Severity, 
Smoking, Family history) and healthy control. 
P-value 
Control 
(60) 
Asthmatic patients 
(100) Variable 
Mean± SD No. Mean± SD No. 
P˂0.05 
1.456±0.244 25 0.693±0.392* 43 7-35 
Age/ year 1.594±0.303 20 0.574±0.407 37 36-50 
1.688±0.518 15 0.485±0.351 25 ˃50 
P˂0.05 
1.462±0.749 35 0.820±0.386 47 Male 
Sex 
1.527±0.930 25 0.700±0.377 53 Female 
P˂0.05 1.745±0.730 60 
1.278±0.524* 32 Mild 
Severity 1.027±0.777 17 Moderate 
0.712±0.447 51 Sever 
P˂0.05 
1.482±0.807 33 0.703±0.674* 25 Positive 
Smoking 
1.770±0.919 27 0.484±0.164 75 Negative 
P˂0.05 1.654±0.429 60 
0.519±0.261* 35 Positive 
Family history 
0.782±0.431 65 Negative 
* The mean difference is significant at the 0.05 level 
 
 
Figure 3. Serum Catalase (U) in asthmatic patients and healthy control classified according to (Age, Sex, 
Severity, Smoking and Family history). 
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